Outcome of Advanced EGFR-Mutated NSCLC Patients with MET-Driven Acquired Resistance to EGFR TKI. Results of the METEORE Study

被引：0
|
作者：
Baldacci, Simon [1 ]
Mazieres, Julien [2 ]
Tomasini, Pascale [3 ]
Girard, Nicolas [4 ]
Guisier, Florian [5 ]
Valette, Clarisse Audigier [6 ]
Monnet, Isabelle [7 ]
Wislez, Marie [8 ]
Perol, Maurice [9 ]
Do, Pascal [10 ]
Dansin, Eric [11 ]
Leduc, Charlotte [12 ]
Leprieur, Etienne Giroux [13 ]
Moro-Sibilot, Denis [14 ]
Kherrouche, Zoulika [15 ]
Labreuche, Julien [16 ]
Cortot, Alexis [1 ]
机构：
[1] Univ Lille, CHU Lille, Serv Pneumol & Oncol Thorac, Lille, France
[2] Toulouse Univ Hosp, Toulouse, France
[3] AP HM, Dept Multidisciplinary Oncol & Therapeut Innovat, Marseille, France
[4] Hosp Civils Lyon, Louis Pradel Hosp, Resp Med, Lyon, France
[5] Rouen Univ Hosp, Rouen, France
[6] Ctr Hosp St Musse, Toulon, France
[7] Ctr Hosp Intercommunal Creteil, Creteil, France
[8] Hop Tenon, Serv Pneumol, AP HP, Paris, France
[9] Ctr Leon Berard, Grp Thorac & Orl, Lyon, France
[10] Ctr Reg Lutte Contre Le Canc Francois Baclesse, Caen, France
[11] Ctr Oscar Lambret, Lille, France
[12] CHU Strasbourg, Strasbourg, France
[13] Hop Ambroise Pare, AP HP, Boulogne, France
[14] Pole Thorax & Vaisseaux, Unite Oncol Thorac, Serv Pneumol, Grenoble, France
[15] Univ Lille, CNRS, Inst Pasteur Lille, Inst Biol Lille,Umr 8161, Lille, France
[16] Univ Lille, Ea 2694, Lille, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
MET amplification; non-small cell lung cancer; EGFR mutation; TKI resistance;
D O I：
10.1016/j.jtho.2016.11.1718
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-051
引用
收藏
页码：S1219 / S1220
页数：2
相关论文
共 50 条
  • [31] MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer
    Pietrantonio, Filippo
    Oddo, Daniele
    Gloghini, Annunziata
    Valtorta, Emanuele
    Berenato, Rosa
    Barault, Ludovic
    Caporale, Marta
    Busico, Adele
    Morano, Federica
    Gualeni, Ambra Vittoria
    Alessi, Alessandra
    Siravegna, Giulia
    Perrone, Federica
    Di Bartolomeo, Maria
    Bardelli, Alberto
    de Braud, Filippo
    Di Nicolantonio, Federica
    CANCER DISCOVERY, 2016, 6 (09) : 963 - 971
  • [32] Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI's: Exploration of efficacy of unselected treatment in a multicenter cohort study
    Steendam, Christi M. J.
    Ernst, Sophie M.
    Badrising, Sushil K.
    Paats, Marthe S.
    Aerts, Joachim G. J. V.
    de Langen, Adrianus J.
    Dingemans, Anne-Marie C.
    LUNG CANCER, 2023, 181
  • [33] Effect of longitudinal ctDNA monitoring with resistance genomic signatures on prognostication in patients with EGFR-mutated advanced NSCLC
    Prabhash, Kumar
    Bharde, Atul
    Behel, Vichitra
    Ratnaparkhi, Mrunal
    Noronha, Vanita
    Patil, Vijay Maruti
    Choughule, Anuradha
    Chandrani, Pratik
    Dutt, Amit
    Jadhav, Bhagwat
    Prajapati, Sangeeta
    Haldar, Sumit
    Mobeen, Fauzul
    Menon, Nandini Sharrel
    Hariramani, Kanchan
    Basavalingegowda, Madhura
    Chaturvedi, Pankaj
    Khandare, Jayant
    Shafi, Gowhar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
    Leonetti, A.
    Verze, M.
    Minari, R.
    Perrone, F.
    Gnetti, L.
    Bordi, P.
    Pluchino, M.
    Nizzoli, R.
    Azzoni, C.
    Bottarelli, L.
    Lagrasta, C. A. M.
    Mazzaschi, G.
    Buti, S.
    Gasparro, D.
    Cosenza, A.
    Ferri, L.
    Majori, M.
    De Filippo, M.
    Ampollini, L.
    La Monica, S.
    Alfieri, R.
    Silini, E. M.
    Tiseo, M.
    BRITISH JOURNAL OF CANCER, 2024, 130 (01) : 135 - 142
  • [35] Cigarette Smoke Extract Exposure Induces EGFR-Tki Resistance In EGFR-Mutated Nsclc Via Mediating Src Activation And Emt
    Chen, H.
    Li, D.
    Zhang, L.
    Zhou, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [36] Cigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMT
    Li, Dandan
    Zhang, Lu
    Zhou, Junhao
    Chen, Hong
    LUNG CANCER, 2016, 93 : 35 - 42
  • [37] ONO-7475, a novel AXL inhibitor, suppresses the adaptive resistance to initial EGFR-TKI treatment in EGFR-mutated NSCLC
    Okura, Naoko
    Taniguchi, Hirokazu
    Tanimura, Keiko
    Horinaka, Mano
    Sakai, Toshiyuki
    Tanaka, Kohei
    Kozaki, Ryohei
    Yano, Seiji
    Yamada, Tadaaki
    CANCER SCIENCE, 2021, 112 : 891 - 891
  • [38] Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
    A. Leonetti
    M. Verzè
    R. Minari
    F. Perrone
    L. Gnetti
    P. Bordi
    M. Pluchino
    R. Nizzoli
    C. Azzoni
    L. Bottarelli
    C. A. M. Lagrasta
    G. Mazzaschi
    S. Buti
    D. Gasparro
    A. Cosenza
    L. Ferri
    M. Majori
    M. De Filippo
    L. Ampollini
    S. La Monica
    R. Alfieri
    E. M. Silini
    M. Tiseo
    British Journal of Cancer, 2024, 130 : 135 - 142
  • [39] Tepotinib Plus an EGFR TKI in Patients with EGFR-mutant NSCLC and Resistance to EGFR TKIs Due to MET Amplification (METamp)
    Liam, C. K.
    Ahmad, A. Rozila
    Hsia, T.
    Li, J. Y.
    Le, X.
    Heymach, J.
    Yang, J. C.
    Soo, R.
    Zhang, Y.
    Kim, S.
    Shin, S. W.
    Johne, A.
    Karachaliou, N.
    Bruns, R.
    Ellers-Lenz, B.
    Wu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1118 - S1119
  • [40] Association of plasma EGFR T790M ctDNA status with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.
    Zheng, Di
    Ye, Xin
    Zhang, Meizhuo
    Sun, Yun
    Wang, Jiying
    Ni, Jian
    Zhang, Haiping
    Zhang, Ling
    Luo, Jie
    Zhang, Jie
    Tang, Liang
    Su, Bo
    Chen, Gang
    Zhu, Guanshan
    Gu, Yi
    Xu, Jianfang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345